A Study of Avastin (Bevacizumab) in Patients With Multiple Myeloma

Clinical trial NCT02079519 · TERMINATED

Trial details

NCT number: NCT02079519
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2006-05-01
Primary completion: 2008-05-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.